•
Dec 31, 2023
Bio-Techne Q2 2024 Earnings Report
Bio-Techne's Q2 2024 earnings were released, revealing a slight revenue increase and mixed segment performance amid challenging macroeconomic conditions.
Key Takeaways
Bio-Techne reported flat revenue growth in the second quarter of fiscal year 2024, with organic revenue declining by 2%. GAAP EPS was $0.17, while adjusted EPS was $0.40. The company faced headwinds from BioPharma macroeconomic conditions but saw strength in the academic end market and growth in instrument consumables.
Organic revenue declined by 2% to $272.6 million.
GAAP EPS was $0.17, and adjusted EPS was $0.40.
Instrument consumables grew by 20%, offsetting BioPharma headwinds.
Cash flow from operations increased by 18% to $142.5 million.
Bio-Techne
Bio-Techne
Bio-Techne Revenue by Segment
Revenue & Expenses
Visualization of income flow from segment revenue to net income